Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2012; 18(41): 5948-5956
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5948
Table 2 Demographic and treatment success of patients and pattern of dysrhythmia according to prokinetic drugs
Itopide (n = 24)Mosapride (n = 28)Levosulpiride (n = 22)
Male:female (n)5:1910:1811:11
Age (range), yr49.8 (30-64)49.6 (19-70)56.6 (39-70)
Height166.1 ± 10.1163.0 ± 11.0167.1 ± 13.2
Weight60.8 ± 7.7 62.7 ± 11.5 61.3 ± 10.5
Symptom improvement18 (75)17 (61)17 (77)
Pre-treatmentPost-treatmentPre-treatmentPost-treatmentPre-treatmentPost-treatment
Symptom severity score7.96 ± 0.845.00 ± 0.86a7.61 ± 0.645.46 ± 0.79a8.86 ± 0.766.14 ± 0.76a
Symptom frequency score9.21 ± 0.926.08 ± 0.99a8.86 ± 0.786.86 ± 0.899.86 ± 0.837.55 ± 0.96
Gastric dysrhythmia (pre-prandial)
Bradygastri5 (20.8)4 (16.7)6 (21.4)4 (14.3)4 (18.2)3 (13.6)
Normogastria8 (33.3)17 (70.8)a15 (53.6)18 (64.3)12 (54.5)15 (68.2)
Tachygastria11 (45.8)3 (12.6)a7 (25)6 (21.4)6 (27.3)4 (18.2
Gastric dysrhythmia (post-prandial)
Bradygastria5 (20.8)3 (12.5)6 (21.4)6 (21.4)3 (13.6)1 (4.5)
Normogastria11 (45.8)14 (58.3)12 (42.9)16 (57.1)14 (63.6)15 (68.2)
Tachygastria8 (33.3)7 (29.2)10 (35.7)6 (21.4)5 (22.7)6 (27.3)